PCM
Polaris Capital Management’s Pacira BioSciences PCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-5,600
| Closed | -$160K | – | 94 |
|
|
2024
Q2 | $160K | Hold |
5,600
| – | – | 0.01% | 91 |
|
|
2024
Q1 | $164K | Sell |
5,600
-16,400
| -75% | -$479K | 0.01% | 91 |
|
|
2023
Q4 | $742K | Sell |
22,000
-3,300
| -13% | -$111K | 0.04% | 89 |
|
|
2023
Q3 | $776K | Hold |
25,300
| – | – | 0.04% | 83 |
|
|
2023
Q2 | $1.01M | Hold |
25,300
| – | – | 0.04% | 80 |
|
|
2023
Q1 | $1.03M | Hold |
25,300
| – | – | 0.04% | 78 |
|
|
2022
Q4 | $977K | Buy |
25,300
+13,400
| +113% | +$517K | 0.03% | 81 |
|
|
2022
Q3 | $633K | Hold |
11,900
| – | – | 0.02% | 88 |
|
|
2022
Q2 | $694K | Buy |
11,900
+3,300
| +38% | +$192K | 0.02% | 85 |
|
|
2022
Q1 | $656K | Hold |
8,600
| – | – | 0.02% | 91 |
|
|
2021
Q4 | $517K | Buy |
+8,600
| New | +$517K | 0.02% | 95 |
|